Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | GABRP | O00591 | 2/20 | 0.30 |
| ▸ | GABRD | O14764 | 2/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.30 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.30 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6666348 | 0.93 | ALDH1A1 (0.48) | ALDH1A1TP53TSHRCA1LTA4H | |
| SCHEMBL494013 | 0.91 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA1LTA4H | |
| SCHEMBL494900 | 0.91 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA1LTA4H | |
| SCHEMBL3059308 | 0.91 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA1LTA4H | |
| SCHEMBL495140 | 0.91 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA1LTA4H | |
| SCHEMBL494087 | 0.91 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA1LTA4H | |
| SCHEMBL495251 | 0.91 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA1LTA4H | |
| SCHEMBL494185 | 0.91 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA1LTA4H | |
| SCHEMBL495750 | 0.91 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA1LTA4H | |
| SCHEMBL495948 | 0.91 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11124472-B2 | Myocardial regeneration promoting compounds, preparation method thereof, and pharmaceutical composition | GENHEALTH PHARMA CO., LTD. (TW) | 2021-09-21 | — | — | US | claimed |
| EP-3725763-A1 | MYOCARDIAL REGENERATION PROMOTING COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION, AND THEIR USE | Genhealth Pharma Co., Ltd. (TW) | 2020-10-21 | — | — | EP | claimed |
| US-20200317602-A1 | MYOCARDIAL REGENERATION PROMOTING COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION, AND THEIR USE | GENHEALTH PHARMA CO., LTD. (TW) | 2020-10-08 | — | — | US | claimed |
| CN-107503132-A | A kind of method for being knitted fabric post processing | 安徽宝源帽业有限公司 | 2017-12-22 | — | — | CN | claimed |
| CN-106700949-A | Multifunctional polishing paste and preparation method and usage method thereof | 安徽雷萨重工机械有限公司 | 2017-05-24 | — | — | CN | claimed |
| EP-0792873-A1 | N-(Phenoxyalkyl) carboxamides and their use as antiarrhythmic agents | American Cyanamid Company (US) | 1997-09-03 | — | — | EP | claimed |
| EP-4735046-A1 | BIOCONJUGATION SYSTEMS AND USES THEREOF | Université de Tours (FR) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025003392-A1 | BIOCONJUGATION SYSTEMS AND USES THEREOF | UNIVERSITÉ DE TOURS (FR) | 2025-01-02 | — | — | WO | disclosed |
| US-20240408218-A1 | CONJUGATES OF GLUCAGON AND AMPK ACTIVATORS | Københavns Universitet (DK) | 2024-12-12 | — | — | US | disclosed |
| US-20240307517-A1 | DEVELOPMENT OF A HIGHLY EFFICIENT SECOND GENERATION FENTANYL-CONJUGATE VACCINE TO TREAT FENTANYL ADDICTION | CORNELL UNIVERSITY (US) | 2024-09-19 | — | — | US | disclosed |
| EP-3504267-B1 | OLIGOESTERS COMPOSITIONS AND METHODS OF MAKING AND USING SAME | KRATON CHEMICAL LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| EP-4408475-A1 | CONJUGATES OF GLUCAGON AND AMPK ACTIVATORS | Københavns Universitet (DK) | 2024-08-07 | — | — | EP | disclosed |
| EP-3635056-B1 | LIGHT COLOR ROSIN ESTER COMPOSITIONS AND METHODS OF MAKING SAME | KRATON POLYMERS LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-0123543-B1 | LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION AND USE AND COMPOSITIONS CONTAINING THEM | MERCK FROSST CANADA INC. (CA) | 1988-02-03 | — | — | EP | disclosed |
| US-4617371-A | CHOLESTERIC | Blumstein, Alexandre (US) | 1986-10-14 | — | — | US | disclosed |
| US-4609744-A | 4-oxo-benzopyran carboxylic acids | MERCK FROSST CANADA INC. (CA) | 1986-09-02 | — | — | US | disclosed |
| EP-0123543-A1 | Leukotriene antagonists, their production and use and compositions containing them | MERCK FROSST CANADA INC. (CA) | 1984-10-31 | — | — | EP | disclosed |
| US-4145516-A | INCORPORATING A DIOL CONTAINING A KETONE CARBONYL | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 1979-03-20 | — | — | US | disclosed |
| US-4136100-A | BLUE-VIOLET TO GREEN-BLUE DYEINGS ON CELLULOSE TEXTILES | BASF AKTIENGESELLSCHAFT (DE) | 1979-01-23 | — | — | US | disclosed |
| US-3940390-A | Process for the production of 2,3,4,5,6,7-hexahydrocyclopenta-(3)-1,3-oxazine-2,4-dione compounds | BAYER AKTIENGESELLSCHAFT (DT) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200317602-A1 | MYOCARDIAL REGENERATION PROMOTING COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION, AND THEIR USE | TNNI3, TNNT2, MYLK2 | ALDH1A1 220/4885TP53 4860/4885TSHR 3979/4885 |
| US-20240408218-A1 | CONJUGATES OF GLUCAGON AND AMPK ACTIVATORS | GLP1R, PRKAG1, GCGR | ALDH1A1 3012/4885TP53 1836/4885TSHR 123/4885 |
| US-11124472-B2 | Myocardial regeneration promoting compounds, preparation method thereof, and pharmaceutical composition | TNNI3, MYLK2, TNNT2 | ALDH1A1 281/4885TP53 4857/4885TSHR 3875/4885 |
| US-20240307517-A1 | DEVELOPMENT OF A HIGHLY EFFICIENT SECOND GENERATION FENTANYL-CONJUGATE VACCINE TO TREAT FENTANYL ADDICTION | OPRK1, OPRM1, OPRD1 | ALDH1A1 1976/4885TP53 4280/4885TSHR 2553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.